nuance wrote:......Have there been advances in implant material that prevent the formation of biofilm?
The material (coating) advancements have certainly contributed to about 50% reduction but not 100% prevention. More surface area, more biofilms.
2018 Dec Translational Andrology and Urology journal
Penile prosthesis biofilm formation and emerging therapies against them
Advancements in implant technology and antiseptic device preparation have decreased infection rates to approximately 1–3% in recent years (13). The two producers of 3-piece IPPs in the US have developed infection-retardant coatings on their implants to reduce infection rates. Boston Scientific (Marlborough, MA) uses a coating of rifampin and minocycline called InhibiZone®. Coloplast Corporation (Humlebaek, Denmark) coats its devices with polyvinylpyrrolidone, a hydrophilic substance that absorbs the antibiotics the IPP is bathed in immediately prior to implantation (10). In a large observational study comparing the infection rates of 1,944 non-coated to 2,261 InhibiZone®-coated IPPs, Carson reported a 50% reduction in infections at 180 days in the coated group (14).
...To further improve outcomes and the risk of infection, many surgeons have also adopted the “no touch” technique during procedures, as popularized by Eid (15). In this method, the implant, the instruments, and the surgeon’s hands never make contact with the patient’s skin during the operation. When paired with infection retardant coated IPPs, this “no touch” technique further reduces the rate of infection to 0.46%
Despite these advances in technology and technique, infections continue to occur. In a recent multicenter investigation of organisms cultured at the time of IPP salvage or explant, 204 organisms were identified (17). The three most prevalent organisms cultured were Escherichia coli (18.3%), followed by coagulase-negative Staphylococcus species (15%), and Candida species (11.1%).